News

ESI, INM, HUN, OLN: Shareholder Deals Under Scrutiny

ESI, INM, HUN, OLN: Shareholder Deals Under Scrutiny

What’s Happening Behind Closed Doors?

Some days, it seems like corporate boardrooms are bustling with secretive deals only a select few get to savor. Case in point: Element Solutions Inc. (NYSE: ESI), InMed Pharmaceuticals, Inc. (NASDAQ: INM), Huntsman Corporation (NYSE: HUN), and Olin Corporation (NYSE: OLN) are in the spotlight, raising eyebrows on whether their shareholders are truly getting the fair shake they've been promised.

Insiders in the Spotlight

The talk of the town isn’t just the structures of these proposed deals—it's who's possibly reaping the real rewards. Insiders might walk away with pockets full, while regular shareholders might be left questioning what's left in it for them. These transactions seem peppered with juicy terms that could prevent better offers from showing up at the party.

Legal Eagles to the Rescue?

Enter Halper Sadeh LLC, an investor rights law firm with a mission to ruffle some corporate feathers. They're probing into these transactions for potential breaches of the federal securities laws or fiduciary duties. Their goal? To make sure shareholders don't get the short end of the stick.

Halper Sadeh LLC may seek increased consideration, additional disclosures, and other benefits on behalf of shareholders. It’s all about holding the big shots accountable.

Let's Break Down These Deals

  • Element Solutions Inc. (NYSE: ESI): It's a straight-up cash and stock play—$10.00 in cash plus 0.500 shares of Solstice common stock for each Element share. The kicker? After this dance, Element shareholders are wearing only 44% of the combined company’s hat.
  • InMed Pharmaceuticals, Inc. (NASDAQ: INM): Following their tango with Mentari Therapeutics, InMed’s part in the pomp is a measly 1.51% shed from the combined new name tag. If that doesn't get shareholders gawking, what will?
  • Huntsman Corporation (NYSE: HUN): Selling over to Olin Corporation, it's an exchange of 0.5476 shares of Olin for each shiny Huntsman share. Is that a fair swap? That's for the legal eagles to contest.
  • Olin Corporation (NYSE: OLN): As the merge-maker with Huntsman, Olin's owning a hefty 54.5% chunk of the resultant corporate pie. Could they be overreaching, or is it just the nature of the beast?

Taking the Legal Route

This isn't Halper Sadeh's first rodeo. They're all about representing investors who've been wronged, raking in reforms and millions for those trampled by corporate tomfoolery. The firm is on alert, pushing for shareholders' rights to be upheld, making sure they aren't unfairly sidelined by these maneuvers.

What’s Next for Investors?

If you’re one of the shareholders watching these moves unfold, it might be time to gear up. There's merit in standing your ground and ensuring these transactions don’t leave you holding the bag. Halper Sadeh’s contingent fee structure means no upfront costs, just potential justice.

Investors, it's time to weigh your options—literally and figuratively. The world of stock trading is a tumultuous brand of unpredictability, but you can ride the waves by staying informed. It's stories like these that remind us: it's not just about the weight of the wallet, but about the principles we're willing to uphold in the game.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arkestro Recognized as Leading Sourcing Tech Solution in 2024

Updated Category News Views 138

Arkestro Celebrated as a Leading Sourcing Technology Provider Arkestro's innovative Predictive Procurement Orchestration AI platform has been recognized among the top contenders in the industry. This recognition comes as part of Spend Matters' release of their Fall 2024 SolutionMap, which acknowledges the leading procurement technology vendors. Out of 93 companies...

Continue Reading
Nanoscope Therapeutics Welcomes Ademola Daramola as VP of Quality

Updated Category News Views 178

Nanoscope Therapeutics Expands Leadership Team Nanoscope Therapeutics Inc., a dedicated biotechnology firm, strives to restore vision for blind patients through pioneering gene therapies. The company has recently appointed Ademola Daramola, D.Sc., as the Vice President of Quality and Compliance. Introducing Dr. Ademola Daramola Dr. Daramola joins Nanoscope with an...

Continue Reading
Lumentum Holdings Readies for Earnings Report with Optimism

Updated Category News Views 220

Lumentum Holdings Prepares for Earnings Release Lumentum Holdings (NASDAQ: LITE) is set to announce its quarterly earnings soon. Investors are eager to see what insights will emerge from the report, as expectations build around the company's performance. Investor Expectations and Earnings Forecast Analysts predict that Lumentum Holdings will post an earnings per share...

Continue Reading
LightPath Technologies Launches Infrared Solutions for Defense

Updated Category News Views 130

LightPath Technologies Initiates Delivery of Infrared Assemblies FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025 LightPath Technologies, Inc. (NASDAQ: LPTH), renowned for its advanced optics and imaging systems targeted at both defense and commercial utilizations, has announced that it...

Continue Reading
The RealReal Boosts Revenue and Adjusted EBITDA in Q3 2024

Updated Category News Views 57

Strong Q3 2024 Performance for The RealReal The RealReal (NASDAQ: REAL), a leader in the online marketplace for authenticated, resale luxury goods, reported significant financial gains in the third quarter of 2024. The company achieved a revenue of $148 million, which represents an increase of $15 million or 11% compared to the previous year. Notably, they also saw...

Continue Reading